Bringing the fundamentals into focus…
Back to Pharming Group N.V.
How Pharming Group N.V. stacks up
PHAR · against 588 other Healthcare companies listed in US-listed
Valuation
42/ 100
Above the middle of the pack.
Ranked #219 of 589 · scores higher than 62% of peers
Bars: peers in each 10-point band of the valuation score45 peers with a valuation score of 40–49, including PHAR · Click a bar to see the companies
Why valuation scores 42?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- Earnings yield is close to the peer norm. Earnings yield: 0.2% vs peer median 1.5%
- EBITDA yield is close to the peer norm. EBITDA yield: 3.8% vs peer median 4.0%
- more free cash flow for the price paid: stronger than 72% of peers. Free cash flow yield: 2.9% vs peer median 0.0%
Metric by metric
Position: dot = PHAR, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | PHAR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | 1.1% | -4.3% | 68% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 3.8% | -0.8% | 64% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | 3.8% | -2.3% | 75% | 20% | |
| Book yieldHigher is better · 587 reported | 29.5% | 25.9% | 55% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around PHAR| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 215 | 15.7B USD | 43 | 33 | |
| 219 | 56.7B USD | 42 | 79 | |
| 219 | 5.1B USD | 42 | 52 | |
| 219 | 1.1B USD | 42 | 31 | |
| 219 | 915M USD | 42 | 57 | |
| 219 | 2.7B USD | 42 | 56 | |
| 219 | 5.8B USD | 42 | 38 | |
| 225 | 7.7B USD | 41 | 37 | |
| 225 | 13.2B USD | 41 | 30 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score